Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(a) On March 12, 2020, Stanley Hirsch resigned as Chairman and Director of both

OWC Pharmaceutical Research Corp. (the "Company") and its wholly-owned

Israeli subsidiary, One World Cannabis Ltd ("One World Cannabis") and as a

member of the Company's Audit Committee.

(b) On March 12, 2020, the Company's Board of Directors appointed Mr. Amir Ohad


    to the Board of Directors.

Amir Ohad, age 57, has served as the Chairman of OHK Medical Devices, Inc., a company which manufactures and sells innovative orthopedic and vascular surgery products, since 2015. Mr. Ohad also serves as a director of Massivit 3D Printing Technologies Ltd. and iSonea (Israel) Ltd. Mr. Ohad has served as an associate in the International Institute for Counter-Terrorism at the Interdisciplinary Academic Institution in Hertzeliya, Israel since 2017. Mr. Ohad served more than 25 years of as a senior executive in private and public companies. From 2005 to 2007, Mr. Ohad served as the chief executive officer of Alqemia Group (Kafrit Industries), a publicly traded specialty compounding firm and served as the chief financial officer of ScitexVision (acquired by Hewlett Packard in 2005) from 2000 to 2005.

Mr. Ohad received his Masters of Business Administration and Masters of Arts from The Hebrew University of Jerusalem.

(c) On March 13, 2020, the Company appointed Mr. Amir Ohad as Chairman of the

Company and One World Cannabis. Mr. Ohad will receive a base salary of $7,500

per month for a minimum period of six (6) months.

© Edgar Online, source Glimpses